Maze Therapeutics, Inc. ( MAZE) - Key Metrics
MAZE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.76 | -$0.26 | -$0.26 |
| 2026Q1 | $0.37 | -$0.45 | -$0.73 | -$0.73 |
| 2025Q4 | $0 | -$0.80 | -$0.65 | -$0.65 |
| 2025Q3 | $0 | -$0.66 | -$0.54 | -$0.54 |
| 2025Q2 | $0 | -$0.77 | -$0.69 | -$0.69 |
MAZE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.82 |
| 2026Q1 | 0% | -16.58 |
| 2025Q4 | 0% | -11.91 |
| 2025Q3 | 0% | -9.82 |
| 2025Q2 | 0% | -3.98 |
MAZE
Price: $28.87
52 week price:
Earnings Per Share: -2.37 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.5 billion